Indeed, ESRP2, SRPK1 and RBM3 have a crucial role in maintaining the appropriate splicing process, and their dysregulation has been described and associated with worse clinical characteristics in tumour pathologies, including HCC.27, 28, 29. This evidence concerns the gene RBM3 and neoplasm.